Shatabdi Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 19-12-2024
- Paid Up Capital ₹ 1.96 M
as on 19-12-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.53 M
as on 19-12-2024
- Revenue 40.67%
(FY 2022)
- Profit -10.29%
(FY 2022)
- Ebitda -9.06%
(FY 2022)
- Net Worth 7.31%
(FY 2022)
- Total Assets 8.29%
(FY 2022)
About Shatabdi Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.96 M.
The company currently has active open charges totaling ₹7.53 M.
Shyamalendu Mandal, Sabita Baidya, and Yuvaraj Mandal serve as directors at the Company.
- CIN/LLPIN
U85110WB2008PTC124540
- Company No.
124540
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shatabdi Diagnostics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyamalendu Mandal  | Director | 27-Mar-2008 | Current |
| Sabita Baidya | Director | 21-Aug-2008 | Current |
| Yuvaraj Mandal | Additional Director | 28-Nov-2022 | Current |
Financial Performance of Shatabdi Diagnostics.
Shatabdi Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.67% increase. The company also saw a substantial fall in profitability, with a 10.29% decrease in profit. The company's net worth moved up by a moderate rise of 7.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shatabdi Diagnostics?
In 2022, Shatabdi Diagnostics had a public holding of 87.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.53 M
₹0
Charges Breakdown by Lending Institutions
- Siemens Financial Services Private Limited : 0.60 Cr
- The Royal Bank Of Scotland N.V : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2014 | Siemens Financial Services Private Limited | ₹6.00 M | Open |
| 12 Jul 2010 | The Royal Bank Of Scotland N.V | ₹1.53 M | Open |
How Many Employees Work at Shatabdi Diagnostics?
Unlock and access historical data on people associated with Shatabdi Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shatabdi Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shatabdi Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
